Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Nuclear Medicine

Free Subscription Articles published in Semin Nucl Med Retrieve available abstracts of 179 articles: HTML format

Single Articles

July 2021
1. PILKINGTON P, Lopci E, Adam JA, Kobe C, et al
   FDG-PET/CT Variants and Pitfalls in Haematological Malignancies.
   Semin Nucl Med. 2021 Jul 13. pii: S0001-2998(21)00046.
   PubMed     Abstract available
   
   
   
2. MEI R, Farolfi A, Castellucci P, Nanni C, et al
   PET/CT variants and pitfalls in prostate cancer: What you might see on PET and should never forget.
   Semin Nucl Med. 2021 Jul 12. pii: S0001-2998(21)00048.
   PubMed     Abstract available
   
   
   
3. DEJANOVIC D, Hansen NL, Loft A
   PET/CT Variants and Pitfalls in Gynecological Cancers.
   Semin Nucl Med. 2021 Jul 9. pii: S0001-2998(21)00038.
   PubMed     Abstract available
   
   
   
4. VAN DE WIELE C, Juanito G, Vander BK, Ismaheel L, et al
   Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients.
   Semin Nucl Med. 2021 Jul 7. pii: S0001-2998(21)00042.
   PubMed     Abstract available
   
   
   
5. PIJL JP, Nienhuis PH, Kwee TC, Glaudemans AWJM, et al
   Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation.
   Semin Nucl Med. 2021 Jul 7. pii: S0001-2998(21)00040.
   PubMed     Abstract available
   
   
   
6. TSAI YJ, Liu C
   Pitfalls on PET/CT Due to Artifacts and Instrumentation.
   Semin Nucl Med. 2021 Jul 6. pii: S0001-2998(21)00047.
   PubMed     Abstract available
   
   
   
7. VASIREDDI A, Nguyen NC
   PET/CT limitations and pitfalls in urogenital cancers.
   Semin Nucl Med. 2021 Jul 6. pii: S0001-2998(21)00045.
   PubMed     Abstract available
   
   
   
8. AGRAWAL A, Shah S, Gnanasegaran G, Rajkotia S, et al
   PET/CT Normal Variants and Pitfalls in Pediatric disorders.
   Semin Nucl Med. 2021 Jul 6. pii: S0001-2998(21)00039.
   PubMed     Abstract available
   
   
   
9. BENZ MR, Crompton JG, Harder D
   PET/CT variants and pitfalls in bone and soft tissue sarcoma.
   Semin Nucl Med. 2021 Jul 5. pii: S0001-2998(21)00041.
   PubMed     Abstract available
   
   
   June 2021
10. MILLS RA, Thompson RC
    Cardiac PET and SPECT During the COVID-19 Pandemic.
    Semin Nucl Med. 2021 Jun 22. pii: S0001-2998(21)00052.
    PubMed     Abstract available
    
    
    
11. EIBSCHUTZ LS, Rabiee B, Asadollahi S, Gupta A, et al
    FDG-PET/CT of COVID-19 and Other Lung Infections.
    Semin Nucl Med. 2021 Jun 22. pii: S0001-2998(21)00049.
    PubMed     Abstract available
    
    
    
12. GIAMMARILE F, Delgado Bolton RC, El-Haj N, Mikhail M, et al
    Impact of COVID-19 on Nuclear Medicine Departments in Africa and Latin America.
    Semin Nucl Med. 2021 Jun 22. pii: S0001-2998(21)00050.
    PubMed     Abstract available
    
    
    
13. PAEZ D, Mikhail-Lette M, Gnanasegaran G, Dondi M, et al
    Nuclear Medicine Departments in the Era of COVID-19.
    Semin Nucl Med. 2021 Jun 22. pii: S0001-2998(21)00051.
    PubMed     Abstract available
    
    
    
14. ANTONIOS L, Chen W, Dilsizian V
    The Impact of COVID-19 on Nuclear Medicine Operations Including Cardiovascular Manifestations in the USA.
    Semin Nucl Med. 2021 Jun 17. pii: S0001-2998(21)00035.
    PubMed     Abstract available
    
    
    
15. BOM HH, Pascual TN, Choudhury PS, Al-Ibraheem A, et al
    Impact of COVID-19 on Nuclear Medicine in Asia.
    Semin Nucl Med. 2021 Jun 16. pii: S0001-2998(21)00033.
    PubMed     Abstract available
    
    
    
16. KIKANO EG, Avril S, Marshall H, Jones RS, et al
    PET/CT Variants and Pitfalls in Breast Cancers.
    Semin Nucl Med. 2021 Jun 1. pii: S0001-2998(21)00021.
    PubMed     Abstract available
    
    
    May 2021
17. ARSLAN E, Cermik TF
    PET/CT Variants and Pitfalls in Liver, Biliary Tract, Gallbladder and Pancreas.
    Semin Nucl Med. 2021 May 25. pii: S0001-2998(21)00022.
    PubMed     Abstract available
    
    
    
18. SINGH V, Dorbala S
    Normal Variants and Pitfalls in Cardiac PET/CT.
    Semin Nucl Med. 2021 May 25. pii: S0001-2998(21)00020.
    PubMed     Abstract available
    
    
    
19. AFAQ A, Faul D, Chebrolu VV, Wan S, et al
    Pitfalls on PET/MRI.
    Semin Nucl Med. 2021 May 18. pii: S0001-2998(21)00019.
    PubMed     Abstract available
    
    
    
20. LOPCI E, Kobe C, Gnanasegaran G, Adam JA, et al
    "PET/CT Variants and Pitfalls in Lung Cancer and Mesothelioma".
    Semin Nucl Med. 2021 May 11. pii: S0001-2998(21)00018.
    PubMed     Abstract available
    
    
    
21. JAYAPRAKASAM VS, Paroder V, Schoder H
    Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers.
    Semin Nucl Med. 2021 May 5. pii: S0001-2998(21)00017.
    PubMed     Abstract available
    
    
    
22. MIHAILOVIC J, Killeen RP, Duignan JA
    PET/CT Variants and Pitfalls in Head and Neck Cancers Including Thyroid Cancer.
    Semin Nucl Med. 2021 May 1. pii: S0001-2998(21)00015.
    PubMed     Abstract available
    
    
    April 2021
23. IMPERIALE A, Meuter L, Pacak K, Taieb D, et al
    Variants and Pitfalls of PET/CT in Neuroendocrine Tumors.
    Semin Nucl Med. 2021 Apr 7. pii: S0001-2998(21)00014.
    PubMed     Abstract available
    
    
    
24. CECCHIN D, Garibotto V, Law I, Goffin K, et al
    PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls.
    Semin Nucl Med. 2021 Apr 3. pii: S0001-2998(21)00016.
    PubMed     Abstract available
    
    
    March 2021
25. RAFIEE F, Keshavarz P, Katal S, Assadi M, et al
    Coronavirus Disease 2019 (COVID-19) in Molecular Imaging: A Systematic Review of Incidental Detection of SARS-CoV-2 Pneumonia on PET Studies.
    Semin Nucl Med. 2021;51:178-191.
    PubMed     Abstract available
    
    
    
26. SEIFERT R, Weber M, Kocakavuk E, Rischpler C, et al
    Artificial Intelligence and Machine Learning in Nuclear Medicine: Future Perspectives.
    Semin Nucl Med. 2021;51:170-177.
    PubMed     Abstract available
    
    
    
27. WEI L, El Naqa I
    Artificial Intelligence for Response Evaluation With PET/CT.
    Semin Nucl Med. 2021;51:157-169.
    PubMed     Abstract available
    
    
    
28. KRARUP MMK, Krokos G, Subesinghe M, Nair A, et al
    Artificial Intelligence for the Characterization of Pulmonary Nodules, Lung Tumors and Mediastinal Nodes on PET/CT.
    Semin Nucl Med. 2021;51:143-156.
    PubMed     Abstract available
    
    
    
29. ZAHARCHUK G, Davidzon G
    Artificial Intelligence for Optimization and Interpretation of PET/CT and PET/MR Images.
    Semin Nucl Med. 2021;51:134-142.
    PubMed     Abstract available
    
    
    
30. HATT M, Cheze Le Rest C, Antonorsi N, Tixier F, et al
    Radiomics in PET/CT: Current Status and Future AI-Based Evolutions.
    Semin Nucl Med. 2021;51:126-133.
    PubMed     Abstract available
    
    
    
31. CURRIE G, Hawk KE
    Ethical and Legal Challenges of Artificial Intelligence in Nuclear Medicine.
    Semin Nucl Med. 2021;51:120-125.
    PubMed     Abstract available
    
    
    
32. DELSO G, Cirillo D, Kaggie JD, Valencia A, et al
    How to Design AI-Driven Clinical Trials in Nuclear Medicine.
    Semin Nucl Med. 2021;51:112-119.
    PubMed     Abstract available
    
    
    
33. CURRIE G, Rohren E
    Intelligent Imaging in Nuclear Medicine: the Principles of Artificial Intelligence, Machine Learning and Deep Learning.
    Semin Nucl Med. 2021;51:102-111.
    PubMed     Abstract available
    
    
    February 2021
34. MINOSHIMA S, Mosci K, Cross D, Thientunyakit T, et al
    Brain [F-18]FDG PET for Clinical Dementia Workup: Differential Diagnosis of Alzheimer's Disease and Other Types of Dementing Disorders.
    Semin Nucl Med. 2021 Feb 2. pii: S0001-2998(21)00002.
    PubMed     Abstract available
    
    
    January 2021
35. JACENE HA
    FDG PET for Assessment of Autologous Stem Cell Transplantation.
    Semin Nucl Med. 2021 Jan 30. pii: S0001-2998(21)00001.
    PubMed     Abstract available
    
    
    
36. DUPONT P
    A Role of PET/MR Imaging in Dementia?
    Semin Nucl Med. 2021 Jan 30. pii: S0001-2998(21)00003.
    PubMed     Abstract available
    
    
    
37. VAN WAARDE A, Marcolini S, de Deyn PP, Dierckx RAJO, et al
    PET Agents in Dementia: An Overview.
    Semin Nucl Med. 2021 Jan 23. pii: S0001-2998(20)30131.
    PubMed     Abstract available
    
    
    
38. CHIH S, Wiefels CC, Beanlands RSB
    PET Assessment of Cardiac Allograft Vasculopathy.
    Semin Nucl Med. 2021 Jan 19. pii: S0001-2998(20)30133.
    PubMed     Abstract available
    
    
    
39. SONG H, Guja KE, Iagaru A
    (18)F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD).
    Semin Nucl Med. 2021 Jan 15. pii: S0001-2998(20)30132.
    PubMed     Abstract available
    
    
    
40. MIKAIL N, Khalil A, Rouzet F
    Mediastinal Masses: (18)F-FDG-PET/CT Features Based on the International Thymic Malignancy Interest Group Classification.
    Semin Nucl Med. 2021;51:79-97.
    PubMed     Abstract available
    
    
    
41. MARCUS C, Subramaniam RM
    Role of Non-FDG-PET/CT in Head and Neck Cancer.
    Semin Nucl Med. 2021;51:68-78.
    PubMed     Abstract available
    
    
    
42. STROHL MP, Ha PK, Flavell RR, Yom SS, et al
    PET/CT in Surgical Planning for Head and Neck Cancer.
    Semin Nucl Med. 2021;51:50-58.
    PubMed     Abstract available
    
    
    
43. HUELLNER MW
    PET/MR in Head and Neck Cancer - An Update.
    Semin Nucl Med. 2021;51:26-38.
    PubMed     Abstract available
    
    
    
44. WONG WL
    PET-CT for Staging and Detection of Recurrence of Head and Neck Cancer.
    Semin Nucl Med. 2021;51:13-25.
    PubMed     Abstract available
    
    
    
45. WAREHAM NE, Nielsen SD, Sorensen SS, Fischer BM, et al
    FDG PET/CT for Detection of Infectious Complications Following Solid Organ Transplantation.
    Semin Nucl Med. 2021 Jan 1. pii: S0001-2998(20)30130.
    PubMed     Abstract available
    
    
    November 2020
46. FIELDS BKK, Demirjian NL, Dadgar H, Gholamrezanezhad A, et al
    Imaging of COVID-19: CT, MRI, and PET.
    Semin Nucl Med. 2020 Nov 30. pii: S0001-2998(20)30123.
    PubMed     Abstract available
    
    
    
47. JOHNSON GB, Harms HJ, Johnson DR, Jacobson MS, et al
    PET Imaging of Tumor Perfusion: A Potential Cancer Biomarker?
    Semin Nucl Med. 2020;50:549-561.
    PubMed     Abstract available
    
    
    
48. COOK GJR, Goh V
    A Role for FDG PET Radiomics in Personalized Medicine?
    Semin Nucl Med. 2020;50:532-540.
    PubMed     Abstract available
    
    
    
49. CHO SY, Huff DT, Jeraj R, Albertini MR, et al
    FDG PET/CT for Assessment of Immune Therapy: Opportunities and Understanding Pitfalls.
    Semin Nucl Med. 2020;50:518-531.
    PubMed     Abstract available
    
    
    September 2020
50. MORADI F, Iagaru A
    The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer.
    Semin Nucl Med. 2020;50:434-446.
    PubMed     Abstract available
    
    
    July 2020
51. SLOMKA PJ, Miller RJ, Isgum I, Dey D, et al
    Application and Translation of Artificial Intelligence to Cardiovascular Imaging in Nuclear Medicine and Noncontrast CT.
    Semin Nucl Med. 2020;50:357-366.
    PubMed     Abstract available
    
    
    
52. HARMS HJ, Sorensen J
    First-Pass Techniques Applied to Standard Dynamic Cardiac PET: A reappraisal of Old Invasive Techniques to Assess Cardiac Function.
    Semin Nucl Med. 2020;50:349-356.
    PubMed     Abstract available
    
    
    
53. WAN N, Travin MI
    Cardiac Imaging With (123)I-meta-iodobenzylguanidine and Analogous PET Tracers: Current Status and Future Perspectives.
    Semin Nucl Med. 2020;50:331-348.
    PubMed     Abstract available
    
    
    
54. MAHMOOD M, Abu Saleh O
    The Role of 18-F FDG PET/CT in Imaging of Endocarditis and Cardiac Device Infections.
    Semin Nucl Med. 2020;50:319-330.
    PubMed     Abstract available
    
    
    
55. LAIREZ O, Hyafil F
    A Clinical Role of PET in Atherosclerosis and Vulnerable Plaques?
    Semin Nucl Med. 2020;50:311-318.
    PubMed     Abstract available
    
    
    May 2020
56. RISCHPLER C, Siebermair J, Kessler L, Quick HH, et al
    Cardiac PET/MRI: Current Clinical Status and Future Perspectives.
    Semin Nucl Med. 2020;50:260-269.
    PubMed     Abstract available
    
    
    
57. MADSEN S, Dias AH, Lauritsen KM, Bouchelouche K, et al
    Myocardial Viability Testing by Positron Emission Tomography: Basic Concepts, Mini-Review of the Literature and Experience From a Tertiary PET Center.
    Semin Nucl Med. 2020;50:248-259.
    PubMed     Abstract available
    
    
    
58. MAANIITTY T, Knuuti J, Saraste A
    15O-Water PET MPI: Current Status and Future Perspectives.
    Semin Nucl Med. 2020;50:238-247.
    PubMed     Abstract available
    
    
    
59. DI CARLI MF
    PET Perfusion and Flow Assessment: Tomorrows' Technology Today.
    Semin Nucl Med. 2020;50:227-237.
    PubMed     Abstract available
    
    
    
60. PIEKARSKI E, Manrique A, Rouzet F, Le Guludec D, et al
    Current Status of Myocardial Perfusion Imaging With New SPECT/CT Cameras.
    Semin Nucl Med. 2020;50:219-226.
    PubMed     Abstract available
    
    
    
61. KLEIN R, Celiker-Guler E, Rotstein BH, deKemp RA, et al
    PET and SPECT Tracers for Myocardial Perfusion Imaging.
    Semin Nucl Med. 2020;50:208-218.
    PubMed     Abstract available
    
    
    March 2020
62. SGOUROS G
    Dosimetry, Radiobiology and Synthetic Lethality: Radiopharmaceutical Therapy (RPT) With Alpha-Particle-Emitters.
    Semin Nucl Med. 2020;50:124-132.
    PubMed     Abstract available
    
    
    
63. DE PALMA D
    Erratum to "Radionuclide tools in clinical management of febrile UTI in children": Seminars in Nuclear Medicine Volume 50, Issue 1, January 2020, Pages 50-55.
    Semin Nucl Med. 2020;50:118.
    PubMed    
    
    
    January 2020
64. BAILEY DL, Roach PJ
    A Brief History of Lung Ventilation and Perfusion Imaging Over the 50-Year Tenure of the Editors of Seminars in Nuclear Medicine.
    Semin Nucl Med. 2020;50:75-86.
    PubMed     Abstract available
    
    
    
65. ARNON-SHELEG E, Israel O, Keidar Z
    PET/CT Imaging in Soft Tissue Infection and Inflammation-An Update.
    Semin Nucl Med. 2020;50:35-49.
    PubMed     Abstract available
    
    
    
66. ZUCKIER LS
    Evidence-Based Medicine in the Domain of Nuclear Medicine, the Fifty-Year View.
    Semin Nucl Med. 2020;50:110-114.
    PubMed     Abstract available
    
    
    
67. DE PALMA D
    Radionuclide Tools in Clinical Management of Febrile UTI in Children.
    Semin Nucl Med. 2020;50:50-55.
    PubMed     Abstract available
    
    
    
68. SATHEKGE MM, Bouchelouche K
    Letter From the Editors.
    Semin Nucl Med. 2020;50:1-4.
    PubMed    
    
    
    November 2019
69. UMUTLU L, Antoch G, Herrmann K, Grueneisen J, et al
    PET/MR Imaging of the Female Pelvis.
    Semin Nucl Med. 2019;49:512-520.
    PubMed     Abstract available
    
    
    
70. PONISIO MR, Dehdashti F
    A Role of PET Agents Beyond FDG in Gynecology.
    Semin Nucl Med. 2019;49:501-511.
    PubMed     Abstract available
    
    
    
71. KEMPPAINEN J, Hynninen J, Virtanen J, Seppanen M, et al
    PET/CT for Evaluation of Ovarian Cancer.
    Semin Nucl Med. 2019;49:484-492.
    PubMed     Abstract available
    
    
    
72. KILCOYNE A, Chow DZ, Lee SI
    FDG-PET for Assessment of Endometrial and Vulvar Cancer.
    Semin Nucl Med. 2019;49:471-483.
    PubMed     Abstract available
    
    
    
73. GANDY N, Arshad MA, Park WE, Rockall AG, et al
    FDG-PET Imaging in Cervical Cancer.
    Semin Nucl Med. 2019;49:461-470.
    PubMed     Abstract available
    
    
    
74. LIN AJ, Dehdashti F, Grigsby PW
    Molecular Imaging for Radiotherapy Planning and Response Assessment for Cervical Cancer.
    Semin Nucl Med. 2019;49:493-500.
    PubMed     Abstract available
    
    
    September 2019
75. CUTLER CS
    Economics of New Molecular Targeted Personalized Radiopharmaceuticals.
    Semin Nucl Med. 2019;49:450-457.
    PubMed     Abstract available
    
    
    
76. IBRAHIM A, Vallieres M, Woodruff H, Primakov S, et al
    Radiomics Analysis for Clinical Decision Support in Nuclear Medicine.
    Semin Nucl Med. 2019;49:438-449.
    PubMed     Abstract available
    
    
    
77. SHEIKH A, Anolik J, Maurer AH
    Update on Serum Glucose and Metabolic Management of Clinical Nuclear Medicine Studies: Current Status and Proposed Future Directions.
    Semin Nucl Med. 2019;49:411-421.
    PubMed     Abstract available
    
    
    
78. SCHREUDER N, Koopman D, Jager PL, Kosterink JGW, et al
    Adverse Events of Diagnostic Radiopharmaceuticals: A Systematic Review.
    Semin Nucl Med. 2019;49:382-410.
    PubMed     Abstract available
    
    
    
79. LEE ST, Burvenich I, Scott AM
    Novel Target Selection for Nuclear Medicine Studies.
    Semin Nucl Med. 2019;49:357-368.
    PubMed     Abstract available
    
    
    
80. VERMEULEN K, Vandamme M, Bormans G, Cleeren F, et al
    Design and Challenges of Radiopharmaceuticals.
    Semin Nucl Med. 2019;49:339-356.
    PubMed     Abstract available
    
    
    July 2019
81. MENA E, Lindenberg LM, Choyke PL
    New Targets for PET Molecular Imaging of Prostate Cancer.
    Semin Nucl Med. 2019;49:326-336.
    PubMed     Abstract available
    
    
    
82. WESTER HJ, Schottelius M
    PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy.
    Semin Nucl Med. 2019;49:302-312.
    PubMed     Abstract available
    
    
    
83. SHEIKHBAHAEI S, Werner RA, Solnes LB, Pienta KJ, et al
    Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls.
    Semin Nucl Med. 2019;49:255-270.
    PubMed     Abstract available
    
    
    May 2019
84. GARIN E, Rolland Y, Edeline J
    (90)Y-Loaded Microsphere SIRT of HCC Patients With Portal Vein Thrombosis: High Clinical Impact of 99mTc-MAA SPECT/CT-Based Dosimetry.
    Semin Nucl Med. 2019;49:218-226.
    PubMed     Abstract available
    
    
    
85. TAFTI BA, Padia SA
    Dosimetry of Y-90 Microspheres Utilizing Tc-99m SPECT and Y-90 PET.
    Semin Nucl Med. 2019;49:211-217.
    PubMed     Abstract available
    
    
    
86. VAN ROEKEL C, Reinders MTM, van der Velden S, Lam MGEH, et al
    Hepatobiliary Imaging in Liver-directed Treatments.
    Semin Nucl Med. 2019;49:227-236.
    PubMed     Abstract available
    
    
    
87. MOADEL RM, Cynamon J
    Letter from the Guest Editors.
    Semin Nucl Med. 2019;49:168-169.
    PubMed    
    
    
    
88. FREEMAN LM, Blaufox MD
    Letter from the Editors.
    Semin Nucl Med. 2019;49:167.
    PubMed    
    
    
    March 2019
89. FREEMAN LM, Donald Blaufox M
    Seminars in Nuclear Medicine March 2019.
    Semin Nucl Med. 2019;49:83-84.
    PubMed    
    
    
    
90. DONOHOE K, Ahuja S
    Society of Nuclear Medicine and Molecular Imaging Efforts Toward Standardization: From Procedure Standards to Appropriate Use Criteria.
    Semin Nucl Med. 2019;49:153-160.
    PubMed     Abstract available
    
    
    
91. FERGUSSON D, Zuckier LS
    Letter From the Guest Editors.
    Semin Nucl Med. 2019;49:85-86.
    PubMed    
    
    
    
92. WILSON M, Moher D
    The Changing Landscape of Journalology in Medicine.
    Semin Nucl Med. 2019;49:105-114.
    PubMed     Abstract available
    
    
    January 2019
93. LE ROUX PY, Hicks RJ, Siva S, Hofman MS, et al
    PET/CT Lung Ventilation and Perfusion Scanning using Galligas and Gallium-68-MAA.
    Semin Nucl Med. 2019;49:71-81.
    PubMed     Abstract available
    
    
    
94. BAILEY DL, Farrow CE, Lau EM
    V/Q SPECT-Normal Values for Lobar Function and Comparison With CT Volumes.
    Semin Nucl Med. 2019;49:58-61.
    PubMed     Abstract available
    
    
    
95. BAJC M, Lindqvist A
    Ventilation/Perfusion SPECT Imaging-Diagnosing Other Cardiopulmonary Diseases Beyond Pulmonary Embolism.
    Semin Nucl Med. 2019;49:4-10.
    PubMed     Abstract available
    
    
    
96. SANCHEZ-CRESPO A
    Lung Ventilation/Perfusion Single Photon Emission Computed Tomography (SPECT) in Infants and Children with Nonembolic Chronic Pulmonary Disorders.
    Semin Nucl Med. 2019;49:37-46.
    PubMed     Abstract available
    
    
    
97. ESLICK EM, Stevens MJ, Bailey DL
    SPECT V/Q in Lung Cancer Radiotherapy Planning.
    Semin Nucl Med. 2019;49:31-36.
    PubMed     Abstract available
    
    
    
98. FARROW C, King G
    SPECT Ventilation Imaging in Asthma.
    Semin Nucl Med. 2019;49:11-15.
    PubMed     Abstract available
    
    
    
99. KWOK PCL, Wallin M, Dolovich MB, Chan HK, et al
    Studies of Radioaerosol Deposition in the Respiratory Tract.
    Semin Nucl Med. 2019;49:62-70.
    PubMed     Abstract available
    
    
    
100. SANCHEZ-CRESPO A
     Lung Scintigraphy in the Assessment of Aerosol Deposition and Clearance.
     Semin Nucl Med. 2019;49:47-57.
     PubMed     Abstract available
     
     
     
101. WECHALEKAR K, Garner J, Gregg S
     Pre-surgical Evaluation of Lung Function.
     Semin Nucl Med. 2019;49:22-30.
     PubMed     Abstract available
     
     
     
102. BAILEY DL, Roach PJ
     Letter From the Guest Editors.
     Semin Nucl Med. 2019;49:2-3.
     PubMed    
     
     
     
103. MORTENSEN J, Berg RMG
     Lung Scintigraphy in COPD.
     Semin Nucl Med. 2019;49:16-21.
     PubMed     Abstract available
     
     
     
104. FREEMAN LM, Blaufox MD
     Letter from the Editors.
     Semin Nucl Med. 2019;49:1.
     PubMed    
     
     
     November 2018
105. ZAIDI H, Alavi A, Naqa IE
     Novel Quantitative PET Techniques for Clinical Decision Support in Oncology.
     Semin Nucl Med. 2018;48:548-564.
     PubMed     Abstract available
     
     
     
106. CASTELLUCCI P, Nanni C, Ambrosini V
     Nuclear Medicine Imaging of Prostate Cancer in the Elderly.
     Semin Nucl Med. 2018;48:541-547.
     PubMed     Abstract available
     
     
     
107. REILLY CC, Raynor WY, Hong AL, Kargilis DC, et al
     Diagnosis and Monitoring of Osteoporosis With (18)F-Sodium Fluoride PET: An Unavoidable Path for the Foreseeable Future.
     Semin Nucl Med. 2018;48:535-540.
     PubMed     Abstract available
     
     
     
108. AL-ZAGHAL A, Raynor W, Khosravi M, Guermazi A, et al
     Applications of PET Imaging in the Evaluation of Musculoskeletal Diseases Among the Geriatric Population.
     Semin Nucl Med. 2018;48:525-534.
     PubMed     Abstract available
     
     
     
109. MAITI B, Perlmutter JS
     PET Imaging in Movement Disorders.
     Semin Nucl Med. 2018;48:513-524.
     PubMed     Abstract available
     
     
     
110. MOGHBEL M, Al-Zaghal A, Werner TJ, Constantinescu CM, et al
     The Role of PET in Evaluating Atherosclerosis: A Critical Review.
     Semin Nucl Med. 2018;48:488-497.
     PubMed     Abstract available
     
     
     
111. KHOSRAVI M, Newberg A, Alavi A
     Cognitive Impairment and Dementias.
     Semin Nucl Med. 2018;48:498-512.
     PubMed     Abstract available
     
     
     
112. ALAVI A, Hoilund-Carlsen PF
     Letter from the Guest Editors.
     Semin Nucl Med. 2018;48:485-487.
     PubMed    
     
     
     September 2018
113. THELU-VANYSACKER M, Frederic P, Charles-Edouard T, Alban B, et al
     SPECT/CT in Postoperative Shoulder Pain.
     Semin Nucl Med. 2018;48:469-482.
     PubMed     Abstract available
     
     
     
114. KAMPEN WU, Westphal F, Van den Wyngaert T, Strobel K, et al
     SPECT/CT in Postoperative Foot and Ankle Pain.
     Semin Nucl Med. 2018;48:454-468.
     PubMed     Abstract available
     
     
     
115. VAN DER BRUGGEN W, Hirschmann MT, Strobel K, Kampen WU, et al
     SPECT/CT in the Postoperative Painful Knee.
     Semin Nucl Med. 2018;48:439-453.
     PubMed     Abstract available
     
     
     
116. VAN DEN WYNGAERT T, Paycha F, Strobel K, Kampen WU, et al
     SPECT/CT in Postoperative Painful Hip Arthroplasty.
     Semin Nucl Med. 2018;48:425-438.
     PubMed     Abstract available
     
     
     
117. GNANASEGARAN G, Paycha F, Strobel K, van der Bruggen W, et al
     Bone SPECT/CT in Postoperative Spine.
     Semin Nucl Med. 2018;48:410-424.
     PubMed     Abstract available
     
     
     
118. STROBEL K, van der Bruggen W, Hug U, Gnanasegaran G, et al
     SPECT/CT in Postoperative Hand and Wrist Pain.
     Semin Nucl Med. 2018;48:396-409.
     PubMed     Abstract available
     
     
     
119. PAYCHA F, Gnanasegaran G, Van den Wyngaert T
     Letter from the Guest Editors.
     Semin Nucl Med. 2018;48:395.
     PubMed    
     
     
     
120. FREEMAN LM, Blaufox MD
     Letter from the Editors.
     Semin Nucl Med. 2018;48:393.
     PubMed    
     
     
     July 2018
121. LJUNGBERG M
     Absolute Quantitation of SPECT Studies.
     Semin Nucl Med. 2018;48:348-358.
     PubMed     Abstract available
     
     
     
122. MANNHEIM JG, Schmid AM, Schwenck J, Katiyar P, et al
     PET/MRI Hybrid Systems.
     Semin Nucl Med. 2018;48:332-347.
     PubMed     Abstract available
     
     
     
123. BERG E, Cherry SR
     Innovations in Instrumentation for Positron Emission Tomography.
     Semin Nucl Med. 2018;48:311-331.
     PubMed     Abstract available
     
     
     
124. FREEMAN LM, Blaufox MD
     Editorial: Innovations in Nuclear Medicine Instrumentation.
     Semin Nucl Med. 2018;48:307-308.
     PubMed    
     
     
     
125. TAYLOR AT, Brandon DC, de Palma D, Blaufox MD, et al
     SNMMI Procedure Standard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults With Suspected Upper Urinary Tract Obstruction 1.0.
     Semin Nucl Med. 2018;48:377-390.
     PubMed    
     
     
     
126. TAMURA R, Pratt EC, Grimm J
     Innovations in Nuclear Imaging Instrumentation: Cerenkov Imaging.
     Semin Nucl Med. 2018;48:359-366.
     PubMed     Abstract available
     
     
     May 2018
127. DONDI M, Paez D, Torres L, Marengo M, et al
     Implementation of Quality Systems in Nuclear Medicine: Why It Matters. An Outcome Analysis (Quality Management Audits in Nuclear Medicine Part III).
     Semin Nucl Med. 2018;48:299-306.
     PubMed     Abstract available
     
     
     
128. PACILIO M, Lauri C, Prosperi D, Petitti A, et al
     New SPECT and PET Radiopharmaceuticals for Imaging Inflammatory Diseases: A Meta-analysis of the Last 10 Years.
     Semin Nucl Med. 2018;48:261-276.
     PubMed     Abstract available
     
     
     
129. SOLLINI M, Berchiolli R, Kirienko M, Rossi A, et al
     PET/MRI in Infection and Inflammation.
     Semin Nucl Med. 2018;48:225-241.
     PubMed     Abstract available
     
     
     
130. PIEKARSKI E, Benali K, Rouzet F
     Nuclear Imaging in Sarcoidosis.
     Semin Nucl Med. 2018;48:246-260.
     PubMed     Abstract available
     
     
     
131. FREEMAN LM, Blaufox MD
     Letter from the Editors-May 2018 Issue.
     Semin Nucl Med. 2018;48:197.
     PubMed    
     
     
     March 2018
132. SALMANOGLU E, Kim S, Thakur ML
     Currently Available Radiopharmaceuticals for Imaging Infection and the Holy Grail.
     Semin Nucl Med. 2018;48:86-99.
     PubMed     Abstract available
     
     
     
133. ORDONEZ AA, Jain SK
     Pathogen-Specific Bacterial Imaging in Nuclear Medicine.
     Semin Nucl Med. 2018;48:182-194.
     PubMed     Abstract available
     
     
     
134. KOUIJZER IJE, Mulders-Manders CM, Bleeker-Rovers CP, Oyen WJG, et al
     Fever of Unknown Origin: the Value of FDG-PET/CT.
     Semin Nucl Med. 2018;48:100-107.
     PubMed     Abstract available
     
     
     
135. PALESTRO CJ
     Letter from the Guest Editor.
     Semin Nucl Med. 2018;48:84-85.
     PubMed    
     
     
     
136. FREEMAN LM, Blaufox MD
     Letter from the Editors.
     Semin Nucl Med. 2018;48:83.
     PubMed    
     
     
     
137. SATHEKGE MM, Ankrah AO, Lawal I, Vorster M, et al
     Monitoring Response to Therapy.
     Semin Nucl Med. 2018;48:166-181.
     PubMed     Abstract available
     
     
     
138. PARISI MT, Otjen JP, Stanescu AL, Shulkin BL, et al
     Radionuclide Imaging of Infection and Inflammation in Children: a Review.
     Semin Nucl Med. 2018;48:148-165.
     PubMed     Abstract available
     
     
     
139. ANKRAH AO, Glaudemans AWJM, Maes A, Van de Wiele C, et al
     Tuberculosis.
     Semin Nucl Med. 2018;48:108-130.
     PubMed     Abstract available
     
     
     January 2018
140. CHESON BD
     PET/CT in Lymphoma: Current Overview and Future Directions.
     Semin Nucl Med. 2018;48:76-81.
     PubMed     Abstract available
     
     
     
141. SPECHT L, Berthelsen AK
     PET/CT in Radiation Therapy Planning.
     Semin Nucl Med. 2018;48:67-75.
     PubMed     Abstract available
     
     
     
142. EL-GALALY TC, Gormsen LC, Hutchings M
     PET/CT for Staging; Past, Present, and Future.
     Semin Nucl Med. 2018;48:4-16.
     PubMed     Abstract available
     
     
     
143. KARLS S, Shah H, Jacene H
     PET/CT for Lymphoma Post-therapy Response Assessment in Other Lymphomas, Response Assessment for Autologous Stem Cell Transplant, and Lymphoma Follow-up.
     Semin Nucl Med. 2018;48:37-49.
     PubMed     Abstract available
     
     
     
144. KOBE C, Dietlein M, Hellwig D
     PET/CT for Lymphoma Post-therapy Response Assessment in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma.
     Semin Nucl Med. 2018;48:28-36.
     PubMed     Abstract available
     
     
     
145. GALLAMINI A, Zwarthoed C
     Interim FDG-PET Imaging in Lymphoma.
     Semin Nucl Med. 2018;48:17-27.
     PubMed     Abstract available
     
     
     
146. KOSTAKOGLU L, Chauvie S
     Metabolic Tumor Volume Metrics in Lymphoma.
     Semin Nucl Med. 2018;48:50-66.
     PubMed     Abstract available
     
     
     
147. KOSTAKOGLU L
     Guest Editorial.
     Semin Nucl Med. 2018;48:2-3.
     PubMed    
     
     
     
148. BLAUFOX MD, Freeman LM
     Letter from the Editors.
     Semin Nucl Med. 2018;48:1.
     PubMed    
     
     
     November 2017
149. DONDI M, Torres L, Marengo M, Massardo T, et al
     Comprehensive Auditing in Nuclear Medicine Through the International Atomic Energy Agency Quality Management Audits in Nuclear Medicine Program. Part 2: Analysis of Results.
     Semin Nucl Med. 2017;47:687-693.
     PubMed     Abstract available
     
     
     
150. DONDI M, Torres L, Marengo M, Massardo T, et al
     Comprehensive Auditing in Nuclear Medicine Through the International Atomic Energy Agency Quality Management Audits in Nuclear Medicine (QUANUM) Program. Part 1: the QUANUM Program and Methodology.
     Semin Nucl Med. 2017;47:680-686.
     PubMed     Abstract available
     
     
     
151. WALDMAN LE, Scharf SC
     Bone SPECT/CT of the Spine, Foot, and Ankle: Evaluation of Surgical Patients.
     Semin Nucl Med. 2017;47:639-646.
     PubMed     Abstract available
     
     
     
152. PALESTRO CJ, Love C
     Role of Nuclear Medicine for Diagnosing Infection of Recently Implanted Lower Extremity Arthroplasties.
     Semin Nucl Med. 2017;47:630-638.
     PubMed     Abstract available
     
     
     
153. GARG G, Benchekroun MT, Abraham T
     FDG-PET/CT in the Postoperative Period: Utility, Expected Findings, Complications, and Pitfalls.
     Semin Nucl Med. 2017;47:579-594.
     PubMed     Abstract available
     
     
     September 2017
154. MATHIS CA, Lopresti BJ, Ikonomovic MD, Klunk WE, et al
     Small-molecule PET Tracers for Imaging Proteinopathies.
     Semin Nucl Med. 2017;47:553-575.
     PubMed     Abstract available
     
     
     
155. KILBOURN MR
     Small Molecule PET Tracers for Transporter Imaging.
     Semin Nucl Med. 2017;47:536-552.
     PubMed     Abstract available
     
     
     
156. MACH RH
     Small Molecule Receptor Ligands for PET Studies of the Central Nervous System-Focus on G Protein Coupled Receptors.
     Semin Nucl Med. 2017;47:524-535.
     PubMed     Abstract available
     
     
     
157. JACKSON IM, Scott PJH, Thompson S
     Clinical Applications of Radiolabeled Peptides for PET.
     Semin Nucl Med. 2017;47:493-523.
     PubMed     Abstract available
     
     
     
158. SCHIRRMACHER R, Wangler B, Bailey J, Bernard-Gauthier V, et al
     Small Prosthetic Groups in 18F-Radiochemistry: Useful Auxiliaries for the Design of 18F-PET Tracers.
     Semin Nucl Med. 2017;47:474-492.
     PubMed     Abstract available
     
     
     
159. DONNELLY DJ
     Small Molecule PET Tracers in Drug Discovery.
     Semin Nucl Med. 2017;47:454-460.
     PubMed     Abstract available
     
     
     
160. VAVERE AL, Scott PJH
     Clinical Applications of Small-molecule PET Radiotracers: Current Progress and Future Outlook.
     Semin Nucl Med. 2017;47:429-453.
     PubMed     Abstract available
     
     
     July 2017
161. KUBOTA K, Yamashita H, Mimori A
     Clinical Value of FDG-PET/CT for the Evaluation of Rheumatic Diseases: Rheumatoid Arthritis, Polymyalgia Rheumatica, and Relapsing Polychondritis.
     Semin Nucl Med. 2017;47:408-424.
     PubMed     Abstract available
     
     
     
162. VAN DER BRUGGEN W, Glaudemans AWJM, Vellenga E, Slart RHJA, et al
     PET in Benign Bone Marrow Disorders.
     Semin Nucl Med. 2017;47:397-407.
     PubMed     Abstract available
     
     
     
163. ROHREN EM, Macapinlac HA
     Spectrum of Benign Bone Conditions on NaF-PET.
     Semin Nucl Med. 2017;47:392-396.
     PubMed     Abstract available
     
     
     
164. PARGHANE RV, Basu S
     Dual-time point 18F-FDG-PET and PET/CT for Differentiating Benign From Malignant Musculoskeletal Lesions: Opportunities and Limitations.
     Semin Nucl Med. 2017;47:373-391.
     PubMed     Abstract available
     
     
     
165. PARIDA GK, Roy SG, Kumar R
     FDG-PET/CT in Skeletal Muscle: Pitfalls and Pathologies.
     Semin Nucl Med. 2017;47:362-372.
     PubMed     Abstract available
     
     
     
166. METSER U, Tau N
     Benign Cutaneous and Subcutaneous Lesions on FDG-PET/CT.
     Semin Nucl Med. 2017;47:352-361.
     PubMed     Abstract available
     
     
     
167. ADAMS HJA, Kwee TC
     Guest Editorial on PET of Benign Musculoskeletal Conditions.
     Semin Nucl Med. 2017;47:320-321.
     PubMed    
     
     
     May 2017
168. PELLETIER-GALARNEAU M, Martineau P, Zuckier LS, Pham X, et al
     18F-FDG-PET/CT Imaging of Thoracic and Extrathoracic Tuberculosis in Children.
     Semin Nucl Med. 2017;47:304-318.
     PubMed     Abstract available
     
     
     
169. SIGNORE A, Glaudemans AWJM, Gheysens O, Lauri C, et al
     Nuclear Medicine Imaging in Pediatric Infection or Chronic Inflammatory Diseases.
     Semin Nucl Med. 2017;47:286-303.
     PubMed     Abstract available
     
     
     
170. PARISI MT, Bermo MS, Alessio AM, Sharp SE, et al
     Optimization of Pediatric PET/CT.
     Semin Nucl Med. 2017;47:258-274.
     PubMed     Abstract available
     
     
     
171. KLUGE R, Kurch L, Georgi T, Metzger M, et al
     Current Role of FDG-PET in Pediatric Hodgkin's Lymphoma.
     Semin Nucl Med. 2017;47:242-257.
     PubMed     Abstract available
     
     
     
172. HARRISON DJ, Parisi MT, Shulkin BL
     The Role of 18F-FDG-PET/CT in Pediatric Sarcoma.
     Semin Nucl Med. 2017;47:229-241.
     PubMed     Abstract available
     
     
     
173. MENDICHOVSZKY I, Solar BT, Smeulders N, Easty M, et al
     Nuclear Medicine in Pediatric Nephro-Urology: An Overview.
     Semin Nucl Med. 2017;47:204-228.
     PubMed     Abstract available
     
     
     
174. DRUBACH LA
     Nuclear Medicine Techniques in Pediatric Bone Imaging.
     Semin Nucl Med. 2017;47:190-203.
     PubMed     Abstract available
     
     
     
175. BAR-SEVER Z
     Scintigraphic Evaluation of Gastroesophageal Reflux and Pulmonary Aspiration in Children.
     Semin Nucl Med. 2017;47:275-285.
     PubMed     Abstract available
     
     
     March 2017
176. PFLUGER T, Piccardo A
     Neuroblastoma: MIBG Imaging and New Tracers.
     Semin Nucl Med. 2017;47:143-157.
     PubMed     Abstract available
     
     
     January 2017
177. GUNN RN, Rabiner EA
     Imaging in Central Nervous System Drug Discovery.
     Semin Nucl Med. 2017;47:89-98.
     PubMed     Abstract available
     
     
     
178. TRIFILIEFF P, Ducrocq F, van der Veldt S, Martinez D, et al
     Blunted Dopamine Transmission in Addiction: Potential Mechanisms and Implications for Behavior.
     Semin Nucl Med. 2017;47:64-74.
     PubMed     Abstract available
     
     
     
179. MALLIK A, Drzezga A, Minoshima S
     Clinical Amyloid Imaging.
     Semin Nucl Med. 2017;47:31-43.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: